• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与非西班牙裔患者相比,患有原发性胆汁性胆管炎的西班牙裔患者获得医疗服务的机会减少。

Hispanic Patients with Primary Biliary Cholangitis Have Decreased Access to Care Compared to Non-Hispanics.

作者信息

Rabiee Atoosa, Polanco Nathalie A Pena, Vara Aymara Fernandez De La, Levy Cynthia

机构信息

Department of Gastroenterology and Hepatology, VA Medical Center, Washington DC, USA.

Divison of Digestive Health and Liver Diseases Department of Medicine University of Miami Miller School of Medicine USA.

出版信息

J Clin Transl Hepatol. 2020 Dec 28;8(4):391-396. doi: 10.14218/JCTH.2020.00006. Epub 2020 Oct 29.

DOI:10.14218/JCTH.2020.00006
PMID:33447522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7782121/
Abstract

Hispanic patients with primary biliary cholangitis (PBC) have reduced rates of biochemical response to ursodeoxycholic acid (UDCA) and increased risk of disease progression compared to non-Hispanic patients. In this study, we sought to identify differences in demographics, comorbidities, environmental risk factors and socioeconomic status between Hispanic and non-Hispanic patients with PBC. In a case control study, we analyzed data from Hispanic (=37 females and 1 male) and non-Hispanic (=54 females and 4 males) patients with PBC seen at the University of Miami/Jackson Memorial Hospital from January 1998 through January 2013. Data were obtained by filling out a questionnaire either via phone call, mail, or e-mail. Odds ratios were calculated to measure the association between exposure and outcomes. Baseline demographics, environmental risk factors and comorbidities were similar between Hispanic and non-Hispanic patients with PBC. Hispanic patients were less likely to be married and fewer Hispanics had education beyond high school level compared to non-Hispanics. Sixty four percent of Hispanic patients had a household income of less than $50000, compared to 19.5% of non-Hispanics. Fewer Hispanic patients with PBC had health insurance coverage compared to non-Hispanics (86.5% vs. 98.1%; odds ratio: 0.1, 95% confidence interval: 0-0.9). Differences in disease severity and response to therapy observed in prior studies could not be explained by environmental exposures. In addition to genetic variation, socioeconomic discrepancies (access to care) may further explain these differences.

摘要

与非西班牙裔患者相比,患有原发性胆汁性胆管炎(PBC)的西班牙裔患者对熊去氧胆酸(UDCA)的生化反应率较低,且疾病进展风险增加。在本研究中,我们试图确定患有PBC的西班牙裔和非西班牙裔患者在人口统计学、合并症、环境风险因素和社会经济地位方面的差异。在一项病例对照研究中,我们分析了1998年1月至2013年1月在迈阿密大学/杰克逊纪念医院就诊的患有PBC的西班牙裔患者(37名女性和1名男性)和非西班牙裔患者(54名女性和4名男性)的数据。数据通过电话、邮件或电子邮件填写问卷获得。计算比值比以衡量暴露与结果之间的关联。患有PBC的西班牙裔和非西班牙裔患者在基线人口统计学、环境风险因素和合并症方面相似。与非西班牙裔患者相比,西班牙裔患者结婚的可能性较小,接受高中以上教育的人数也较少。64%的西班牙裔患者家庭收入低于50000美元,而非西班牙裔患者这一比例为19.5%。与非西班牙裔患者相比,患有PBC的西班牙裔患者获得医疗保险的比例较低(86.5%对98.1%;比值比:0.1,95%置信区间:0 - 0.9)。先前研究中观察到的疾病严重程度和治疗反应的差异无法用环境暴露来解释。除了基因变异外,社会经济差异(获得医疗服务的机会)可能进一步解释这些差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b73/7782121/f58646e99087/JCTH-8-391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b73/7782121/7a519e18c316/JCTH-8-391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b73/7782121/f58646e99087/JCTH-8-391-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b73/7782121/7a519e18c316/JCTH-8-391-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b73/7782121/f58646e99087/JCTH-8-391-g002.jpg

相似文献

1
Hispanic Patients with Primary Biliary Cholangitis Have Decreased Access to Care Compared to Non-Hispanics.与非西班牙裔患者相比,患有原发性胆汁性胆管炎的西班牙裔患者获得医疗服务的机会减少。
J Clin Transl Hepatol. 2020 Dec 28;8(4):391-396. doi: 10.14218/JCTH.2020.00006. Epub 2020 Oct 29.
2
Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics.原发性胆汁性肝硬化的西班牙裔患者比非西班牙裔患者更有可能具有自身免疫性肝炎的特征,并且对熊去氧胆酸的反应降低。
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1398-405. doi: 10.1016/j.cgh.2013.12.010. Epub 2013 Dec 17.
3
Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis.原发性胆汁性胆管炎的西班牙裔患者在候补名单上的死亡率增加,且接受肝移植的比率降低。
Clin Gastroenterol Hepatol. 2018 Jun;16(6):965-973.e2. doi: 10.1016/j.cgh.2017.12.017. Epub 2018 Feb 8.
4
Obeticholic acid for the treatment of primary biliary cholangitis.奥贝胆酸用于治疗原发性胆汁性胆管炎。
Expert Opin Pharmacother. 2016 Sep;17(13):1809-15. doi: 10.1080/14656566.2016.1218471. Epub 2016 Aug 9.
5
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.原发性胆汁性胆管炎的发病率上升和治疗后死亡率降低。
Clin Gastroenterol Hepatol. 2018 Aug;16(8):1342-1350.e1. doi: 10.1016/j.cgh.2017.12.033. Epub 2017 Dec 23.
6
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis.熊去氧胆酸治疗原发性胆汁性胆管炎患者肝移植无生存。
J Hepatol. 2019 Aug;71(2):357-365. doi: 10.1016/j.jhep.2019.04.001. Epub 2019 Apr 11.
7
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.意大利原发性胆汁性胆管炎患者大型真实世界队列中对熊去氧胆酸无反应的比率。
Scand J Gastroenterol. 2019 Oct;54(10):1274-1282. doi: 10.1080/00365521.2019.1669702. Epub 2019 Sep 28.
8
Bezafibrate Improves GLOBE and UK-PBC Scores and Long-Term Outcomes in Patients With Primary Biliary Cholangitis.贝扎贝特可改善原发性胆汁性胆管炎患者的 GLOBE 和 UK-PBC 评分及长期结局。
Hepatology. 2019 Dec;70(6):2035-2046. doi: 10.1002/hep.30552. Epub 2019 Apr 12.
9
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis.年龄和性别对原发性胆汁性胆管炎患者熊去氧胆酸反应及肝移植无失败生存率的影响。
Clin Gastroenterol Hepatol. 2019 Sep;17(10):2076-2084.e2. doi: 10.1016/j.cgh.2018.12.028. Epub 2019 Jan 4.
10
The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis.
Hepatol Res. 2021 Jan;51(1):31-38. doi: 10.1111/hepr.13593. Epub 2021 Jan 15.

引用本文的文献

1
Beyond the Surface: Unveiling Hidden Hurdles to Primary Biliary Cholangitis Care.表面之下:揭示原发性胆汁性胆管炎护理中的隐藏障碍。
Cureus. 2024 Jul 17;16(7):e64753. doi: 10.7759/cureus.64753. eCollection 2024 Jul.
2
Disease burden of primary biliary cholangitis and associated pruritus based on a cross-sectional US claims analysis.基于美国横断面索赔分析的原发性胆汁性胆管炎及其相关瘙痒的疾病负担。
BMJ Open Gastroenterol. 2022 Aug;9(1). doi: 10.1136/bmjgast-2021-000857.

本文引用的文献

1
Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.种族/民族与原发性胆汁性胆管炎成人住院死亡率的保险特定差异:2007-2014 年全国住院患者样本分析。
Dig Dis Sci. 2020 Feb;65(2):406-415. doi: 10.1007/s10620-019-05809-x. Epub 2019 Sep 5.
2
Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis.原发性胆汁性胆管炎的西班牙裔患者在候补名单上的死亡率增加,且接受肝移植的比率降低。
Clin Gastroenterol Hepatol. 2018 Jun;16(6):965-973.e2. doi: 10.1016/j.cgh.2017.12.017. Epub 2018 Feb 8.
3
Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics.
原发性胆汁性肝硬化的西班牙裔患者比非西班牙裔患者更有可能具有自身免疫性肝炎的特征,并且对熊去氧胆酸的反应降低。
Clin Gastroenterol Hepatol. 2014 Aug;12(8):1398-405. doi: 10.1016/j.cgh.2013.12.010. Epub 2013 Dec 17.
4
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients.对熊去氧胆酸的生化反应可预测北美原发性胆汁性肝硬化患者队列的生存率。
J Gastroenterol. 2014 Oct;49(10):1414-20. doi: 10.1007/s00535-013-0903-1. Epub 2013 Dec 8.
5
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis.原发性胆汁性肝硬化的流行病学的局限性和潜在亮点。
J Autoimmun. 2013 Oct;46:81-7. doi: 10.1016/j.jaut.2013.06.015. Epub 2013 Jul 17.
6
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.性别和年龄是原发性胆汁性肝硬化临床表型和熊去氧胆酸反应的决定因素。
Gastroenterology. 2013 Mar;144(3):560-569.e7; quiz e13-4. doi: 10.1053/j.gastro.2012.12.005. Epub 2012 Dec 12.
7
Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosis.吸烟是原发性胆汁性肝硬化肝纤维化的独立危险因素。
J Hepatol. 2012 Jan;56(1):218-24. doi: 10.1016/j.jhep.2011.03.031. Epub 2011 May 19.
8
Chronic liver disease in the Hispanic population of the United States.美国西班牙裔人群中的慢性肝病。
Clin Gastroenterol Hepatol. 2011 Oct;9(10):834-41; quiz e109-10. doi: 10.1016/j.cgh.2011.04.027. Epub 2011 May 12.
9
Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis.与原发性胆汁性肝硬化相关的人口统计学、生活方式、医学和家族因素。
J Hepatol. 2010 Jul;53(1):162-9. doi: 10.1016/j.jhep.2010.02.019. Epub 2010 Mar 31.
10
Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations.原发性胆汁性肝硬化危险因素的两项英国人群病例对照研究。
Gut. 2010 Apr;59(4):508-12. doi: 10.1136/gut.2009.184218.